Tantra-Chem India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.15 M
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Tantra-Chem India
Tantra-Chem India Private Limited (TIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 June 2007 and has a history of 17 years and seven months. Its registered office is in Ratnagiri, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.15 M, as per Ministry of Corporate Affairs (MCA) records.
Mandar Adivarekar and Shraddha Kotawadekar serve as directors at the Company.
Company Details
-
Location
Ratnagiri, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100PN2007PTC209573
-
Company No.
171454
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jun 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Tantra-Chem India Private Limited offer?
Tantra-Chem India Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Bromine Compound, Industrial Chemicals & Supplies, Agro Chemicals, Industrial Additive.
Who are the key members and board of directors at Tantra-Chem India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mandar Adivarekar
|
Managing Director | 09-Nov-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shraddha Kotawadekar
|
Director | 09-Nov-2016 | Current |
Financial Performance of Tantra-Chem India.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tantra-Chem India?
Unlock access to Tantra-Chem India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Aarush Pharmacare Private LimitedMandar Adivarekar and Shraddha Kotawadekar are mutual person
-
Aarush Lifesciences Private Limited
Mandar Adivarekar and Shraddha Kotawadekar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tantra-Chem India?
Unlock and access historical data on people associated with Tantra-Chem India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tantra-Chem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tantra-Chem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
